Efficacy of Brolucizumab in Polyp Regression of Treatment-Na ïve Polypoidal Choroidal Vasculopathy and Its Effect on One-Year Treatment Outcome

CONCLUSION: Intravitreal brolucizumab injection effectively improved visual and anatomical outcomes and achieved significant polyp regression in treatment-naïve PCV patients. Complete polyp regression and the reduction rate of vascular lesion size and polyp size after loading injection significantly influence the treatment outcome of PCV patients. However, careful monitoring and preoperative warning is warranted due to occurrence of brolucizumab-related IOI.PMID:38584441 | DOI:10.3341/kjo.2023.0145
Source: Korean Journal of Ophthalmology : KJO - Category: Opthalmology Authors: Source Type: research